Victory Capital Management Inc. Sells 506,009 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Victory Capital Management Inc. decreased its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 93.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,161 shares of the company's stock after selling 506,009 shares during the quarter. Victory Capital Management Inc.'s holdings in Definitive Healthcare were worth $149,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Principal Financial Group Inc. lifted its stake in Definitive Healthcare by 9.7% in the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company's stock valued at $181,000 after buying an additional 3,874 shares during the period. Rhumbline Advisers raised its stake in Definitive Healthcare by 5.2% during the 4th quarter. Rhumbline Advisers now owns 81,316 shares of the company's stock worth $334,000 after buying an additional 4,034 shares during the period. Glenmede Trust Co. NA boosted its holdings in shares of Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock valued at $82,000 after buying an additional 5,362 shares during the period. Nisa Investment Advisors LLC boosted its stake in Definitive Healthcare by 3,652.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock worth $29,000 after purchasing an additional 6,794 shares during the period. Finally, Point72 DIFC Ltd increased its holdings in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after purchasing an additional 8,215 shares in the last quarter. 98.67% of the stock is owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of analysts have commented on DH shares. Barclays cut their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research note on Monday, March 3rd. The Goldman Sachs Group cut their price objective on Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Stephens initiated coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an "equal weight" rating and a $5.00 price target on the stock. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Definitive Healthcare presently has an average rating of "Hold" and a consensus target price of $5.35.

Definitive Healthcare Stock Performance

NASDAQ:DH traded up $0.03 during mid-day trading on Thursday, reaching $2.96. 432,071 shares of the company's stock were exchanged, compared to its average volume of 761,661. Definitive Healthcare Corp. has a one year low of $2.55 and a one year high of $8.35. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The business's fifty day simple moving average is $4.13 and its two-hundred day simple moving average is $4.28. The firm has a market capitalization of $334.22 million, a PE ratio of -0.95, a price-to-earnings-growth ratio of 4.06 and a beta of 1.51.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.04). The business had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.